BETA-LACTAMASE-HEMMER

Patent europeic · EP3882252 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3882252
Numer da la dumonda
EP21157549
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-06-2015
Publitgà
22-09-2021
Concedì
19-11-2025
La protecziun finescha il pli tard
10-06-2035
Proxima taxa annuala scadenta
30-06-2026
Classas IPC
C07F 5/02 (2006.01)
A61K 31/69 (2006.01)
A61K 31/43 (2006.01)
A61P 31/00 (2006.01)
Prioritad
US 201462010969 P 11.06.2014
US 201462010940 P 11.06.2014
US 201462010968 P 11.06.2014
US 201562118227 P 19.02.2015
Derivà da
EP15806746
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-09-2026

    Midada

    Published in Swissreg on 30.09.2026

  2. 16-04-2026

    Owner

    Owner
    Venatorx Pharmaceuticals, Inc., 30 Spring Mill Drive, Malvern, PA 19355, USA → Basilea Pharmaceutica International AG, Allschwil, Hegenheimermattweg 167b, 4123 Allschwil

    Published in Swissreg on 16.04.2026

  3. 19-11-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.11.2025

Partidas

Inventur

BURNS, Christopher J.

Malvern, Pennsylvania 19355, US

DAIGLE, Denis

Maryland 21154, US

LIU, Bin

Dayton, New Jersey 08810, US

JACKSON, Randy W.

Livingston, Montana 59047, US

HAMRICK, Jodie

New Holland, Pennsylvania 17557, US

MCGARRY, Daniel

Malvern, Pennsylvania 19355, US

PEVEAR, Daniel C.

Downingtown, Pennsylvania 19335, US

TROUT, Robert E. Lee

Collegeville, Pennsylvania 19426, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.